BSE Live
Dec 04, 16:01Prev. Close
256.05
Open Price
251.50
Bid Price (Qty.)
251.90 (25)
Offer Price (Qty.)
281.00 (5)
NSE Live
Dec 04, 15:54Prev. Close
255.40
Open Price
255.00
Bid Price (Qty.)
252.25 (1)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Indoco Remedies (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 18.43 | 18.43 | 18.43 | 18.43 | 18.43 | |
| Total Share Capital | 18.43 | 18.43 | 18.43 | 18.43 | 18.43 | |
| Reserves and Surplus | 661.14 | 642.19 | 656.55 | 632.91 | 558.08 | |
| Total Reserves and Surplus | 661.14 | 642.19 | 656.55 | 632.91 | 558.08 | |
| Total Shareholders Funds | 679.57 | 660.62 | 674.98 | 651.34 | 576.51 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 96.93 | 128.66 | 123.28 | 132.31 | 37.89 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 12.82 | 7.32 | 9.61 | 11.43 | 9.69 | |
| Long Term Provisions | 23.29 | 15.95 | 12.70 | 11.28 | 13.54 | |
| Total Non-Current Liabilities | 133.04 | 151.93 | 145.59 | 155.02 | 61.11 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 105.98 | 113.39 | 109.93 | 118.36 | 87.23 | |
| Trade Payables | 165.60 | 170.72 | 149.55 | 164.03 | 131.31 | |
| Other Current Liabilities | 135.81 | 117.13 | 119.66 | 72.16 | 57.38 | |
| Short Term Provisions | 51.59 | 44.26 | 38.22 | 35.84 | 27.03 | |
| Total Current Liabilities | 458.99 | 445.50 | 417.36 | 390.39 | 302.95 | |
| Total Capital And Liabilities | 1,271.60 | 1,258.05 | 1,237.93 | 1,196.75 | 940.58 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 541.62 | 416.62 | 441.11 | 392.80 | 334.37 | |
| Intangible Assets | 48.03 | 50.94 | 47.66 | 47.00 | 38.96 | |
| Capital Work-In-Progress | 7.32 | 141.23 | 75.78 | 40.33 | 5.82 | |
| Fixed Assets | 640.35 | 652.99 | 624.33 | 530.43 | 428.13 | |
| Non-Current Investments | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Deferred Tax Assets [Net] | 35.90 | 35.51 | 31.32 | 27.60 | 21.92 | |
| Long Term Loans And Advances | 1.00 | 1.26 | 1.07 | 1.80 | 1.30 | |
| Other Non-Current Assets | 31.13 | 30.13 | 42.14 | 64.75 | 24.36 | |
| Total Non-Current Assets | 708.49 | 720.00 | 698.97 | 624.70 | 476.03 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 15.68 | |
| Inventories | 208.32 | 183.45 | 193.38 | 186.95 | 166.69 | |
| Trade Receivables | 210.14 | 195.84 | 209.51 | 215.68 | 188.83 | |
| Cash And Cash Equivalents | 37.93 | 36.26 | 11.90 | 62.59 | 12.63 | |
| Short Term Loans And Advances | 0.39 | 0.43 | 0.46 | 0.57 | 0.44 | |
| OtherCurrentAssets | 106.33 | 122.07 | 123.71 | 106.27 | 80.27 | |
| Total Current Assets | 563.10 | 538.05 | 538.96 | 572.05 | 464.55 | |
| Total Assets | 1,271.60 | 1,258.05 | 1,237.93 | 1,196.75 | 940.58 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 51.73 | 25.12 | 52.68 | 86.57 | 79.81 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 6.14 | 6.14 | 6.14 | 6.14 | 6.14 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
25.07.2025
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher